Analyst Ratings for Protagonist Therapeutics (PTGX)
PTGX Rating Summary
PTGX Price Target Summary
- Highest: $165.00 (Citizens)
- Lowest: $73.00 (Leerink)
- Average: $117.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$117.14 (-16.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$117.14 (-16.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/21/2026 | Wolfe Research | Alexandria Hammond | New Coverage | Outperform (N/A) |
135.00 (N/A) |
100.88 (140.91) |
39.68% | Details |
| 9/17/2025 | Barclays » Updated 7/14/2026 |
Etzer Darout | New Coverage | Overweight (N/A) |
151.00 (119.00) |
0.00 (140.91) |
0% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
